Literature DB >> 15860251

Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes.

Nguan Soon Tan1, Liliane Michalik, Beatrice Desvergne, Walter Wahli.   

Abstract

The peroxisome proliferator-activated receptors (PPAR) alpha, beta/delta and gamma belong to the nuclear hormone receptor superfamily. As ligand-activated receptors, they form a functional transcriptional unit upon heterodimerization with retinoid X receptors (RXRs). PPARs are activated by fatty acids and their derivatives, whereas RXR is activated by 9-cis retinoic acid. This heterodimer binds to peroxisome proliferator response elements (PPRE) residing in target genes and stimulates their expression. Recent reports now indicate that PPARs and RXRs can function independently, in the absence of a hetero-partner, to modulate gene expression. Of importance, these non-canonical mechanisms underscore the impact of both cofactors and DNA on gene expression. Furthermore, these different mechanisms reveal the increasing repertoire of PPAR 'target' genes that now encompasses non-PPREs containing genes. It is also becoming apparent that understanding the regulation of PPAR expression and activity, can itself have a significant influence on how the expression of subgroups of target genes is studied and integrated in current knowledge.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15860251     DOI: 10.1016/j.jsbmb.2004.12.025

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  45 in total

1.  Regulation of Wnt/beta-catenin pathway by cPLA2alpha and PPARdelta.

Authors:  Chang Han; Kyu Lim; Lihong Xu; Guiying Li; Tong Wu
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

2.  Real-time recording of circadian liver gene expression in freely moving mice reveals the phase-setting behavior of hepatocyte clocks.

Authors:  Camille Saini; André Liani; Thomas Curie; Pascal Gos; Florian Kreppel; Yann Emmenegger; Luigi Bonacina; Jean-Pierre Wolf; Yves-Alain Poget; Paul Franken; Ueli Schibler
Journal:  Genes Dev       Date:  2013-07-01       Impact factor: 11.361

3.  Human constitutive androstane receptor mediated methotrexate induction of human dehydroepiandrosterone sulfotransferase (hSULT2A1).

Authors:  Xinrong Chen; Jimei Zhang; Sharon M Baker; Guangping Chen
Journal:  Toxicology       Date:  2006-12-22       Impact factor: 4.221

4.  Expression of a peroxisome proliferator-activated receptor gene (xPPARalpha) from Xenopus laevis in tobacco (Nicotiana tabacum) plants.

Authors:  Alejandro G Nila; Luisa M Sandalio; Mercedes G López; Manuel Gómez; Luis A del Rio; Miguel A Gómez-Lim
Journal:  Planta       Date:  2006-08       Impact factor: 4.116

5.  Peroxisome proliferator-activated receptor gamma activation inhibits progesterone-stimulated human MUC1 expression.

Authors:  Peng Wang; Neeraja Dharmaraj; Melissa J Brayman; Daniel D Carson
Journal:  Mol Endocrinol       Date:  2010-05-19

6.  Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats.

Authors:  Sajay B Churi; Omar S Abdel-Aleem; Kiranjeet K Tumber; Heather Scuderi-Porter; Bradley K Taylor
Journal:  J Pain       Date:  2008-04-03       Impact factor: 5.820

Review 7.  Peroxisome proliferator-activated receptor (PPAR): balance for survival in parasitic infections.

Authors:  Marion M Chan; Kyle W Evans; Andrea R Moore; Dunne Fong
Journal:  J Biomed Biotechnol       Date:  2010-02-10

8.  The Role of PPARα Activation in Liver and Muscle.

Authors:  Lena Burri; G Hege Thoresen; Rolf K Berge
Journal:  PPAR Res       Date:  2010-08-18       Impact factor: 4.964

9.  Peroxisome proliferator-activated receptors alpha, Beta, and gamma mRNA and protein expression in human fetal tissues.

Authors:  Barbara D Abbott; Carmen R Wood; Andrew M Watkins; Kaberi P Das; Christopher S Lau
Journal:  PPAR Res       Date:  2010-07-26       Impact factor: 4.964

10.  New target genes for the peroxisome proliferator-activated receptor-γ (PPARγ) antitumour activity: Perspectives from the insulin receptor.

Authors:  Daniela P Foti; Francesco Paonessa; Eusebio Chiefari; Antonio Brunetti
Journal:  PPAR Res       Date:  2009-06-29       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.